STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
STRATEC Biomedical AG
04.05.2012 20:08
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
1. Threadneedle Asset Management Holdings Limited
Threadneedle Asset Management Holdings Limited, London, UK, has notified us
pursuant to sec. 21 para. 1 WpHG on 1 May 2012, that on 26 April 2012 the
share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
DE0007289001 went below the threshold of 5% and that the percentage of
voting rights on that day amounted to 4.89% (570,727 shares). These voting
rights are attributable to Threadneedle Asset Management Holdings Limited
pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.
The voting rights were attributed to Threadneedle Asset Management Holdings
Limited inter alia from Threadneedle Investment Funds ICVC, being a
shareholder holding 3% or more of the voting rights in STRATEC Biomedical
AG.
2. Threadneedle Asset Management Holdings SARL
Threadneedle Asset Management Holdings SARL, Luxembourg, Luxembourg, has
notified us pursuant to sec. 21 para. 1 WpHG on 1 May 2012, that on 26
April 2012 the share of voting rights in STRATEC Biomedical AG, Birkenfeld,
Germany, ISIN: DE0007289001 went below the threshold of 5% and that the
percentage of voting rights on that day amounted to 4,94% (576,485 shares).
These voting rights are attributable to Threadneedle Asset Management
Holdings SARL pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with
sent. 2 WpHG.
The voting rights were attributed to Threadneedle Asset Management Holdings
SARL inter alia from Threadneedle Investment Funds ICVC, being a
shareholder holding 3% or more of the voting rights in STRATEC Biomedical
AG.
3. Ameriprise Financial, Inc.
Ameriprise Financial, Inc., Minneapolis, Minnesota, USA, has notified us
pursuant to sec. 21 para. 1 WpHG on 1 May 2012, that on 26 April 2012 the
share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
DE0007289001 went below the threshold of 5% and that the percentage of
voting rights on that day amounted to 4.99% (582,175 shares). These voting
rights are attributable to Ameriprise Financial, Inc. pursuant to sec. 22
para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.
The voting rights were attributed to Ameriprise Financial, Inc. inter alia
from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or
more of the voting rights in STRATEC Biomedical AG.
4. Threadneedle Asset Management Limited
Threadneedle Asset Management Limited, London, UK, has notified us pursuant
to sec. 21 para. 1 WpHG on 1 May 2012, that on 26 April 2012 the share of
voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
DE0007289001 went below the threshold of 5% and that the percentage of
voting rights on that day amounted to 4.89% (570,727 shares). These voting
rights are attributable to Threadneedle Asset Management Limited pursuant
to sec. 22 para. 1 sent. 1 no. 6.
The voting rights were attributed to Threadneedle Asset Management Limited
inter alia from Threadneedle Investment Funds ICVC, being a shareholder
holding 3% or more of the voting rights in STRATEC Biomedical AG.
04.05.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Internet: www.stratec.com
End of Announcement DGAP News-Service
back